BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29345110)

  • 1. Remarkable similarity in Plasmodium falciparum and Plasmodium vivax geranylgeranyl diphosphate synthase dynamics and its implication for antimalarial drug design.
    Venkatramani A; Gravina Ricci C; Oldfield E; McCammon JA
    Chem Biol Drug Des; 2018 Jun; 91(6):1068-1077. PubMed ID: 29345110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity.
    No JH; de Macedo Dossin F; Zhang Y; Liu YL; Zhu W; Feng X; Yoo JA; Lee E; Wang K; Hui R; Freitas-Junior LH; Oldfield E
    Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4058-63. PubMed ID: 22392982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Structure and Inhibition of a Malaria Drug Target: Geranylgeranyl Diphosphate Synthase.
    G Ricci C; Liu YL; Zhang Y; Wang Y; Zhu W; Oldfield E; McCammon JA
    Biochemistry; 2016 Sep; 55(36):5180-90. PubMed ID: 27564465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
    Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
    J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from Plasmodium falciparum: an insight into novel antimalarial drug design.
    Paul P; Chowdhury A; Das Talukdar A; Choudhury MD
    J Mol Model; 2015 Mar; 21(3):37. PubMed ID: 25663521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.
    Bouillon A; Giganti D; Benedet C; Gorgette O; Pêtres S; Crublet E; Girard-Blanc C; Witkowski B; Ménard D; Nilges M; Mercereau-Puijalon O; Stoven V; Barale JC
    J Biol Chem; 2013 Jun; 288(25):18561-73. PubMed ID: 23653352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A knowledge-based approach for identification of drugs against vivapain-2 protein of Plasmodium vivax through pharmacophore-based virtual screening with comparative modelling.
    Yadav MK; Singh A; Swati D
    Appl Biochem Biotechnol; 2014 Aug; 173(8):2174-88. PubMed ID: 24970047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific Inhibition of the Bifunctional Farnesyl/Geranylgeranyl Diphosphate Synthase in Malaria Parasites via a New Small-Molecule Binding Site.
    Gisselberg JE; Herrera Z; Orchard LM; Llinás M; Yeh E
    Cell Chem Biol; 2018 Feb; 25(2):185-193.e5. PubMed ID: 29276048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adenosine deaminases of Plasmodium vivax and Plasmodium falciparum exhibit surprising differences in ligand specificity.
    Ivanov A; Matsumura I
    J Mol Graph Model; 2012 May; 35():43-8. PubMed ID: 22481078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and structural characterization of PvSERA4: potential implication as therapeutic target for Plasmodium vivax malaria.
    Rahul CN; Shiva Krishna K; Pawar AP; Bai M; Kumar V; Phadke S; Rajesh V
    J Biomol Struct Dyn; 2014 Apr; 32(4):580-90. PubMed ID: 23582016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of first-in-class plasmodium OTU inhibitors with potent anti-malarial activity.
    Siyah P; Akgol S; Durdagi S; Kocabas F
    Biochem J; 2021 Sep; 478(18):3445-3466. PubMed ID: 34486667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic binding insights for 1-deoxy-D-Xylulose-5-Phosphate synthase, the enzyme catalyzing the first reaction of isoprenoid biosynthesis in the malaria-causing protists, Plasmodium falciparum and Plasmodium vivax.
    Battistini MR; Shoji C; Handa S; Breydo L; Merkler DJ
    Protein Expr Purif; 2016 Apr; 120():16-27. PubMed ID: 26699947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, expression and functional activity of deoxyhypusine synthase from Plasmodium vivax.
    Njuguna JT; Nassar M; Hoerauf A; Kaiser AE
    BMC Microbiol; 2006 Oct; 6():91. PubMed ID: 17042947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study.
    Boateng RA; Tastan Bishop Ö; Musyoka TM
    Malar J; 2020 Nov; 19(1):442. PubMed ID: 33256744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
    Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
    Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-oxopurine phosphoribosyltransferase: a target for the development of antimalarial drugs.
    de Jersey J; Holý A; Hocková D; Naesens L; Keough DT; Guddat LW
    Curr Top Med Chem; 2011; 11(16):2085-102. PubMed ID: 21619515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase.
    Hast MA; Fletcher S; Cummings CG; Pusateri EE; Blaskovich MA; Rivas K; Gelb MH; Van Voorhis WC; Sebti SM; Hamilton AD; Beese LS
    Chem Biol; 2009 Feb; 16(2):181-92. PubMed ID: 19246009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico study of M18 aspartyl amino peptidase (M18AAP) of Plasmodium vivax as an antimalarial drug target.
    Rout S; Mahapatra RK
    Bioorg Med Chem; 2019 Jun; 27(12):2553-2571. PubMed ID: 30929948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site.
    Korsinczky M; Fischer K; Chen N; Baker J; Rieckmann K; Cheng Q
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2214-22. PubMed ID: 15155224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.